New Jersey · 2026-2027 Regular Session · Bill
A 2020: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 2020 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient. Primary sponsor: Shama Haider (Democratic). Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Health Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shama Haider | Primary sponsor | Democratic | House | 37 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Health Committee